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A B S T R A C T
Objective: To determine the prevalence of fetal and neonatal deaths among patients with 
maternal near miss and the factors associated with this fatal outcome. 
Methods: The authors conducted a descriptive, cross-sectional, analyzing medical records 
of patients admitted to the ICU of a tertiary obstetric Recife (Brazil), between January 
2007  and December 2010, who had at least one criterion of near miss defined by WHO. 
Statistical analysis was performed with Epi-Info 3.3.2, using chi-square and Fisher’s exact 
test, considering a significance level of 5%. For multivariate analysis was constructed as a 
hierarchical model with the response variable fetal and neonatal deaths. 
Results: We included 246  cases of maternal near miss. Among women in the study, 
hypertensive disorders occurred in 62.7% to 41.2% in HELLP syndrome and the laboratory 
criteria for near miss in 59.6%. There were 48 (19.5%) stillbirths and 19 (7.7%) neonatal deaths. 
After analyzing the variables that remained statistically associated with fetal and neonatal 
deaths were: severe preeclampsia, placental abruption, endometritis, cesarean delivery, 
prematurity and the laboratory criteria for maternal near miss. 
Conclusion: The high incidence of fetal and neonatal deaths among patients with maternal 
near miss. Among these women there is an overlap of factors contributing to this fatal 
outcome, in our study, those who had severe preeclampsia, placental abruption, endometritis, 
premature birth or laboratory criteria positively associated with deaths.
© 2012 Elsevier Editora Ltda. 
Óbitos fetais e neonatais entre casos de near miss materno
R E S U M O
Objetivo: Determinar a prevalência dos óbitos fetais e neonatais entre as pacientes com near 
miss materno e os fatores associados a esse desfecho fatal. 
Métodos: Realizou-se um estudo descritivo, tipo corte transversal, analisando-se prontuários 
das pacientes admitidas na UTI obstétrica de um hospital terciário do Recife (Brasil), entre 
janeiro de 2007  e dezembro de 2010, que apresentavam pelo menos um critério de near 
miss definido pela OMS. A análise estatística foi realizada com o programa Epi-Info 3.3.2, 
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usando os testes Qui-quadrado de associação e exato de Fisher, considerando-se o nível de 
significância de 5%. Para análise multivariada foi construído um modelo hierarquizado tendo 
como variável resposta os óbitos fetais e neonatais. 
Resultados: Foram incluídos 246 casos de near miss. Entre as mulheres do estudo, os distúrbios 
hipertensivos ocorreram em 62,7%, a síndrome HELLP em 41,2% e os critérios laboratoriais 
de near miss em 59,6%. Ocorreram 48 (19,5%) óbitos fetais e 19 (7,7%) óbitos neonatais. Após 
a análise estatística as variáveis que permaneceram associadas aos óbitos fetais e neonatais 
foram: pré-eclâmpsia grave, DPP, endometrite, cesariana, prematuridade e os critérios 
laboratoriais de near miss materno. 
Conclusão: É elevada a ocorrência de óbitos fetais e neonatais entre as pacientes com near 
miss materno. Entre essas mulheres há uma sobreposição de fatores que contribuem para 
esse desfecho fatal, em nosso estudo aquelas que apresentaram pré-eclâmpsia grave, DPP, 
endometrite, parto prematuro ou critérios laboratoriais apresentam associação positiva com 
os óbitos.
Introduction
Cases of maternal near miss, i.e., women in the pregnancy-
childbirth cycle that were very close to death and survived, 
can occur up to 100 times more often than maternal deaths, 
and are currently used to evaluate the care provided by 
hospitals.1-4 The prevalence of near miss varies widely; in 
Latin America, it ranges from 0.34% to 4.92%, depending on the 
defining criteria.5 In a study conducted in Brazil, the prevalence 
of complications was 21.1/1,000 live births.6
Until recently, there was no consensus regarding the criteria 
used to define a case as maternal near miss. Some authors 
used criteria based on a specific disease, while others used 
interventions or organ dysfunction.7-11 In 2009, the World 
Health Organization (WHO) established its own criteria to 
define maternal near miss, and recommended its worldwide 
use. They are: clinical (acute cyanosis, gasping, respiratory 
rate > 40 or < 6/rpm, shock, oliguria unresponsive to fluids 
or diuretics, coagulation disorders, loss of consciousness for 
12 hours or more, loss of consciousness and absence of pulse 
or heartbeat, stroke, uncontrolled seizures, jaundice in the 
presence of PE), laboratory criteria (SO2 < 90% for 60 minutes or 
more, PaO2 / FiO2 < 200 mmHg, creatinine ≥ 3.5 mg/dL, bilirubin 
≥ 6.0 mg/dL, pH < 7.1, lactate > 5, acute thrombocytopenia 
[< 50,000], loss of consciousness, and presence of glucose 
and ketone in the urine), and management criteria3 (use of 
vasoactive drugs, hysterectomy by infection or bleeding, 
transfusion ≥ five units of PRBC, intubation and ventilation 
for ≥ 60 minutes unrelated to anesthesia, dialysis for acute 
renal failure, and cardiorespiratory arrest).
Maternal status during pregnancy and childbirth affect fetal 
and neonatal conditions.12,13 Thus, the maternal near miss, 
a condition in which the woman is critically ill, and which 
increases maternal morbidity, may also contribute to the 
increase in perinatal morbimortality.3,14 Its association with 
adverse perinatal events is expected, and is very strong.15,16
In addition to the increased risk of stillbirth, newborns 
of women with near miss present a higher risk of dying in 
the first week of life, of requiring intensive care unit (ICU) 
hospitalization, and of being small for gestational age.16 
A WHO survey compared 2,952 cases of maternal near miss 
with 94,083 women who did not have this morbidity and 
found an approximately four-fold higher risk of stillbirth and 
neonatal death among the near miss cases.16 However, the 
near miss criteria used (ICU admission, blood transfusion, 
hysterectomy, eclampsia, and renal or cardiac complications) 
were different from that recommended by the WHO.3,16
A descriptive Brazilian study that used the new WHO 
criteria identified, among cases of maternal near miss, a high 
frequency of prematurity and low birth weight, as well as a 
perinatal mortality rate two times higher than that observed 
in that hospital during the same period.17 A study conducted 
in Africa that followed near miss women and their children for 
12 months, which compared them with women without near 
miss, demonstrated that the risk of death among the children 
was five times higher among cases of near miss.18 However, 
when adjusting for other factors, the odds ratio increased and 
the significance decreased (p = 0.08), making this association 
uncertain.18
Although maternal near miss has been the subject of many 
studies, there have been few studies dealing with perinatal 
complications among these patients.14,19 With this purpose, 
the present article described the impact of maternal near 
miss on fetal and neonatal mortality and sought to identify 
the factors associated with fetal and neonatal deaths among 
patients with near miss. 
Methods
The study was conducted after approval by the Research Ethics 
Committee of the Instituto de Medicina Integral Prof. Fernando 
Figueira (IMIP), according to the principles that regulate 
research in humans, and in accordance with resolution 
196/96 of the Brazilian Health Council, Case No. 2028-10, 
on November 19, 2010. The study was performed at IMIP, a 
charity organization located in Recife (Pernambuco, Brazil), 
which is divided into obstetric emergency and maternity 
wards (obstetrics, fetal medicine, human reproduction, and 
© 2012 Elsevier Editora Ltda. Este é um artigo Open Access sob a licença de CC BY-NC-ND
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postpartum care). IMIP also has a 12-bed obstetric ICU; annual 
admission is approximately 800 patients.
This was a cross-sectional and retrospective study that 
identified, among patients admitted to the obstetric ICU of 
IMIP from January of 2007 to December of 2010, those who had 
maternal near miss according to the WHO criteria. During the 
study period, 2,997 women in the pregnancy-childbirth cycle 
were admitted to the obstetric ICU of IMIP. After analyzing 
the medical records, 255 women who met some of the WHO 
maternal near miss criteria were identified. Live children 
born to these participants also had their records analyzed 
to determine neonatal outcome. Data were collected from 
November of 2010 to January of 2012 by the main investigator 
and research assistants, trained in the School of Medicine 
of the Faculdade Pernambucana de Saúde, linked to the 
Institutional Program for Scientific Initiation Scholarships.
The variables studied were age, ethnicity, marital status, 
educational level, origin, income, reproductive history, 
pre-existing diseases, prenatal care, diagnosis of hypertensive 
disorders, postpartum hemorrhage, premature placental 
abruption, sepsis, endometritis, pneumonia, pulmonary 
edema, thrombocytopenia, laparotomy, central access, length 
of hospital stay, gestational age at delivery, type of delivery, 
types of WHO maternal near miss criteria and their moment of 
onset, fetal and neonatal death, Apgar score, and birth weight. 
All data were entered into specific files created in Microsoft 
Excel spreadsheets, 2003 version, and statistical analysis 
was performed using the Epi-info software, release 3.5.3. For 
categorical variables, descriptive analysis was performed with 
a study of frequency and percentage, while for quantitative 
variables, measures of central tendency and their dispersions 
were calculated. Cases of fetal and neonatal death were 
considered adverse fetal and neonatal outcome (AFNO). AFNO 
analysis excluded cases of maternal near miss associated with 
miscarriage (seven), gestational trophoblastic disease (one), 
and ectopic pregnancy (one), as these situations do not include 
viable fetuses. Cases of twin pregnancies were recorded as a 
single outcome, classified by the twin with worse outcome. 
In the bivariate analysis, AFNO was the outcome variable, 
and all others were considered exposure variables, categorized 
as yes/no dichotomous variables. The prevalence ratio (PR) was 
calculated as a measure of risk, with a 95% confidence interval 
(95% CI). Chi-squared or Fisher’s association tests were used 
when pertinent.
Since this was an epidemiological study with a large 
number of mediating or intervening variables conceptually 
related to AFNO, a hierarchical model was constructed for 
multiple logistic regression analysis, as in these situations 
the use of only one hierarchical level is not adequate.20 The 
model was based on another proposed by Lima20 (Fig. 1). The 
variables were positioned hierarchically in four levels (distal, 
intermediate I, intermediate II, and proximal), following a 
temporal and logical order among the events that led to AFNO.
The distal level of the model consisted of maternal socio-
economic and demographic characteristics (education, income, 
ethnicity, origin), which precede or partly determine the 
occurrence of maternal morbidity and reproductive history.20,21 
These characteristics, in turn, were included in the intermediate 
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Fig. 1 – Hierarchical model for fetal and neonatal adverse outcome among patients with maternal near miss, adapted from 
the model of Lima20.
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I level (age, marital status, number of births, miscarriages, 
previous C-section, previous stillbirth, PE, eclampsia, HELLP 
syndrome, premature placental abruption, pneumonia, 
endometritis, sepsis, acute pulmonary edema, exploratory 
laparotomy, central access, and postpartum hemorrhage). 
The intermediate level II included aspects related to 
prenatal care and childbirth (presence or absence of prenatal 
care and type of delivery), as a good quality prenatal care 
should be able to ensure access to an appropriate obstetrics 
unit and to identify the necessities and morbidities of the 
mother.20 The proximal factors included the birth status of 
the newborn (prematurity) and maternal life-threatening 
situations (clinical, laboratory, and management criteria of 
maternal near miss) due to the close association with neonatal 
morbidity and mortality.13,20
It is also noteworthy that among the selection criteria of the 
study participants was the presence of at least one criterion of 
maternal near miss. Thus, there were women who had only 
clinical, laboratory, or management criteria, or an association 
of them. The criteria for near miss could then be divided and 
grouped as proximal factors directly associated with AFNO, 
and it was thus possible to discover among the three (clinical, 
laboratory or management), which would have a greater 
association with AFNO.
The introduction of the variables into a multiple regression 
model was performed in steps. First, a multivariate analysis with 
variables from the distal level showed a significance level of up 
to 20%. In this analysis, the variables with the highest p-value 
were removed from the model, one at a time, until only those 
that had a statistically significant difference remained (p < 0.05), 
which were then selected for the next phase, and thereafter 
were not excluded from the model. The PR obtained in this 
step did not change with the addition of the variables from 
the following levels, reflecting the different weight assigned to 
each level of the model. Then, all variables from intermediate 
level I whose p-value was less than 0.20 were included in the 
model, as well as the variables from the previous level (distal) 
with statistical significance. The process was repeated with the 
following levels, obtaining in the final model the variables that 
remained significantly associated with AFNO (p < 0.05). 
To demonstrate the representativeness of the present 
sample, after collection, sample size was calculated with the 
help of the StatCalc Epi Info program, release 3.5.1, using data 
from the study “Severe maternal morbidity and near miss events 
in a regional referral hospital”, in which the prevalence of fetal 
and neonatal death was 12.5% among patients with maternal 
near miss.17 Thus a sample of 168 patients was obtained, for 
an alpha error of 0.05 and a beta error of 0.20. Considering a 
predicted loss rate of 20%, the total number of participants was 
202. Because this was a descriptive study, as many patients 
as possible were obtained during the time of the study, so the 
number found by calculation was rounded to the total number 
collected in the four years of the study period (246). 
Results
Between January of 2007 and December of 2010, 255 cases of 
maternal near miss were identified among the obstetric patients 
admitted to the ICU of IMIP. During the same period, there were 
19,940 live births in the institution, with a maternal near miss 
ratio of 12.8/1,000 live births. The length of stay ranged from five 
to 86 days, with a mean of 14.8 days (SD = 10.27).
The age of the participants ranged from 14-45 years with 
a mean of 25.6 (SD =  6.99), and among them 57.3% were 
mixed-race, 41.2% had a stable relationship with a partner, 
43.2% had less than eight years of schooling, and 18.8% were 
from Recife. Regarding the obstetric history, 50% of patients were 
nulliparous, 18.8% had a history of miscarriage, 6.3% of stillbirth, 
and 20.5% had had a previous C-section delivery. Regarding the 
analysis of prenatal care, only 12 (4.9%) did not receive it. 
Among the 160 cases of hypertensive disorders, there were 
125 cases (49%) of severe PE, and 35 cases of eclampsia (13.7%). 
HELLP syndrome occurred in 105 (41.2%) participants. The 
most frequent infection was endometritis (25.1%), followed by 
pneumonia (19.6%), and 16.9% of patients developed sepsis. 
There were 90 cases (35.3%) of postpartum hemorrhage, 29 
(11.4%) cases of premature placental abruption (PPA), four 
cases of placenta accreta, three uterine ruptures, and one 
placenta praevia.
The laboratory criteria for near miss were present in 59.6% 
of the participants, while the clinical and management criteria 
were observed in 50.2% and 49%, respectively. C-section was 
the most common type of delivery, with 188 cases (76.4%). The 
mean gestational age at delivery was 34 weeks and two days, 
with 54.5% premature births (gestational age at birth less than 
37 weeks). 
For the analysis of AFNO, seven cases of miscarriage, one 
ectopic pregnancy, and one choriocarcinoma were excluded. 
Thus, among 246 cases of maternal near miss, there were 67 
(27.2%) cases of AFNO, of which 48 (19.5%) occurred due to 
fetal death and 19 (7.7%) due to neonatal death; 44.4% of live 
births were discharged, 9.8% were hospitalized for more than 
28 days, and there was loss of data on neonatal outcome in 
18% of cases. Among the 198 live births, 42 (17.1%) had birth 
weight < 1.5 kg, 30 (12.2%) were less than 30 gestational weeks 
at birth, and 22 (9%) had five-minute Apgar score < 7 . There 
were 12 twin pregnancies.
The highest frequency of fetal and neonatal deaths occurred 
in women who had PPA (73.1%). Among the criteria for maternal 
near miss, the laboratory criteria showed the highest number 
of cases of AFNO (45.1%) (Table 1). In the bivariate analysis, 
AFNO was significantly associated (p < 0.05) with the following 
variables: history of miscarriage, severe PE, HELLP syndrome, 
PPA, endometritis, postpartum hemorrhage, C-section delivery, 
prematurity, and laboratory criteria for maternal near miss 
(Table 1). 
Considering the possible inter-associations between the 
study variables, a logistic regression model with hierarchical 
levels was applied. Among the distal level variables, only one 
had p < 0.20 (Black ethnicity), but it was greater than 0.05, so 
it was not included in the regression analysis. Among the 
intermediate I level variables, a p-value < 0.20 was found 
for age, marital status, nulliparity, history of stillbirth and 
miscarriage, severe PE, HELLP syndrome, PPA, endometritis, 
central access, laparotomy, and postpartum hemorrhage. 
When performing the multiple regression analysis, those with 
p-values < 0.05 were severe PE, PPA, and endometritis (Table 2). 
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AFNO OR (95% CI) p
 Yes n (%) No n (%)   
Distal factors 
 Ethnicity (black) 7 (53.8) 6 (46.2) 1.74 (1.00-3.03) 0.08a
 Schooling (< 8 years) 31 (34.1) 60 (65.9) 1.14 (0.74-1.75) 0.55
 Origin (countryside or RMR) 55 (34) 107 (66) 1.08 (0.64-1.80) 0.78
 Income (no income) 44 (30.6) 100 (69.4) 0.82 (0.50-1.35) 0.45
Intermediate factors I
 Age (35 or older) 11 (50) 11 (50) 1.59 (0.99-2.54) 0.08
 Marital status (no partner) 8 (21.1) 30 (78.9) 0.60 (0.31-1.14) 0.09
 Nulliparous 27 (26.7) 74 (73.3) 0.70 (0.46-1.06) 0.09
 History of C-section 48 (31.8) 103 (68.2) 0.95 (0.59-1.55) 0.85
 History of stillbirth 8 (53.3) 7 (46.7) 1.76 (1.04-2.97) 0.06a
 History of miscarriage 19 (46.3) 22 (53.7) 1.64 (1.08-2.48) 0.03
 Severe pre-eclampsia 44 (43.6) 57 (56.4) 1.88 (1.23-2.86) < 0.05
 Eclampsia 8 (25.8) 23 (74.2) 0.74 (0.40-1.39) 0.32
 HELLP syndrome 39 (44.8) 48 (55.2) 1.81 (1.22-2.69) < 0.05
 PPA 19 (73.1) 7 (26.9) 2.65 (1.89-3.70) < 0.05
 Pneumonia 11 (26.2) 31 (73.8) 0.74 (0.43-1.28) 0.26
 Endometritis 22 (45.8) 26 (54.2) 1.55 (1.04-2.29) 0.03
 Sepsis 10 (31.3) 22 (68.8) 0.92 (0.53-1.60) 0.77
 Acute pulmonary edema 8 (28.6) 20 (71.4) 0.83 (0.45-1.55) 0.55
 Exploratory laparotomy 6 (20.7) 23 (79.3) 0.58 (0.28-1.22) 0.11
 Central access 16 (47.1) 18 (52.9) 1.53 (1.00-2.34) 0.07
 Postpartum hemorrhage 36 (50) 36 (50) 2.06 (1.41-3.03) < 0.05
Intermediate factors II
 C-section delivery 37 (24.8) 112 (75.2) 0.42 (0.29-0.61) <0.05
 Lack of prenatal 4 (44.4) 5 (55.6) 1.44 (0.67-3.08) 0.31a
Proximal factors 
 Prematurity 52 (44.1) 66 (55.9) 4.22 (2.03-8.75) < 0.05
 Clinical near miss 33 (33.3) 66 (66.7) 0.99 (0.67-1.46) 0.96
 Laboratory near miss 51 (45.1) 72 (58.5) 2.00 (1.23-3.24) < 0.05
 Management near miss 28 (31.1) 62 (68.9) 0.88 (0.59-1.31) 0.52
95% CI, 95% confidence interval; AFNO, adverse fetal and neonatal outcome; OR, odds ratio; PPA, premature placental abruption; RMR, Recife 
metropolitan region.
a Analysis performed with Fisher’s test.
Table 1 – Bivariate analysis between the study variables and AFNO among women with near miss.
 Adjusted risk odds ratio   95% CI p
Proximal factorsa — — —
Intermediate factors I
 Endometritis 3.82 1.71-8.58 < 0.05
 PPA 8.86 3.03-25.91 < 0.05
 Severe pre-eclampsia 3.21 1.55-6.63 < 0.05
Intermediate factors II
 C-section delivery 0.20 0.08-0.44 < 0.05
Proximal factors 
 Prematurity 7.20 2.52-20.53 < 0.05
 Laboratory near miss 2.83 1.08-7.39 0.03
95% CI, 95% confidence interval; PPA, premature placental abruption.
a Among the proximal factors, none showed statistical significance.
Table 2 – Multivariate analysis of factors associated with adverse fetal and neonatal outcome among women with near miss.
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The intermediate level II variable, C-section, whose 
adjusted risk was 0.20 (p < 0.05), was added to the model 
with the intermediate level I variables. After this step, the 
proximal level variables ; prematurity and laboratory criteria 
for near miss with p-values < 0.20 were then added. Through 
a multivariate logistic regression analysis, using a hierarchical 
model, only the variables severe PE, PPA, endometritis, 
C-section delivery, prematurity, and laboratory criteria for 
maternal near miss remained significantly associated with 
AFNO (Table 2). The variables history of miscarriage, HELLP 
syndrome, and postpartum hemorrhage lost significance after 
adjusted analysis. 
Discussion
The ratio of maternal near miss in this study was 12.8/1,000 live 
births, similar to that found in a Brazilian study (9.35/1,000) 
that also used the new WHO criteria, and within the wide 
range reported in the literature.5,11,17,22
The number of fetal deaths (19.5%) was higher than that 
observed by other authors16,17 (3.6% and 12.5%). Conversely, 
Souza showed an almost four times higher risk of fetal death 
among patients with maternal near miss when compared 
to women without near miss.16 He also concluded that the 
babies of these patients were small for gestational age, more 
often required neonatal ICU admission, and had a higher 
risk of perinatal death.16 The number of neonatal deaths 
(7.7%) was also higher than that found by Souza (3.2%); this 
difference can be explained by the maternal near miss criteria 
adopted by Souza, which were different from those currently 
recommended by the WHO.14,16
In spite of these differences, it is undeniable that the 
severe obstetric conditions experienced by these women with 
maternal near miss determined a high number of fetal and 
neonatal deaths, as observed in the present study.
Among the children of women with maternal near miss, 
there was a significant proportion of infants with very low birth 
weight (< 1.5 kg), severe hypoxia (5-minute Apgar score < 7) 
and extreme prematurity (gestational age < 30 weeks), which 
were even higher than that reported by other authors.16,17 This 
corroborates the hypothesis that near miss increases not only 
fetal but also neonatal morbidity, as such conditions have high 
sensitivity and specificity to identify neonatal complications.12
When performing the multivariate analysis with a hierar-
chical model, PPA, severe PE, endometritis, C-section delivery, 
prematurity, and laboratory criteria for maternal near miss 
remained significantly associated with AFNO. PPA is an 
obstetric complication with high potential for maternal and 
fetal morbimortality. Adverse perinatal outcomes such as 
low birth weight, prematurity, and perinatal death often 
accompany this diagnosis.23,24  In the present study, PPA 
remained strongly associated with AFNO (PR = 8.86; 95% 
CI = 3.03 to 25.91; p <0.05), corroborating the findings of other 
studies.23,24
Hypertensive disorders are among those most often 
associated with maternal near miss and perinatal morbidity 
and mortality.15,19 In the present study, among women with 
severe PE, almost half had AFNO. The fetuses of mothers 
with severe PE have worse perinatal prognosis, with increased 
risk of prematurity, low birth weight, and death when com-
pared with fetuses of normotensive mothers or those with 
gestational hypertension.25 In this study, in addition to severe 
PE, women had another factor associated with a worse fetal 
and neonatal outcome, which was the near miss. This overlap 
of maternal near miss and severe PE resulted in a strong 
association with AFNO; women with maternal near miss who 
had severe PE had a three times greater association with AFNO 
when compared with patients with near miss who did not have 
severe PE. 
An analysis with a specific group of patients with severe 
PE (those with HELLP syndrome) was also performed. In the 
bivariate analysis, this group showed statistical significance, 
but in the multivariate analysis, only severe PE was strongly 
associated with AFNO, and HELLP syndrome lost significance 
(PR = 1.29; 95% CI = 0.52 to 3.21; p = 0.58). The literature shows 
conflicting results of studies that compared the perinatal 
outcome of patients with HELLP syndrome and cases of severe 
PE.26,27 Among women with near miss, fetal and neonatal 
deaths were more often related with severe PE than with its 
complications (eclampsia or HELLP syndrome). 
This prevalence of hypertensive disorders among cases of 
maternal near miss and its association with AFNO indicates 
the need for prenatal care improvement aimed at the early 
identification and implementation of measures to prevent 
progression to complications and minimize the effects on the 
fetus. This is feasible, as in developed countries there has been 
a reduction in cases of hypertensive disorders; they do not 
appear as the main maternal condition associated with near 
miss, having been replaced by bleeding disorders.28
In a study conducted in Italy with over 1,200 cases of 
maternal near miss, and in another conducted by the WHO 
with almost 3,000 cases, C-section was the main route of 
pregnancy termination, with frequencies of 70% and 59.5%, 
respectively, similar to that found in this study16,28 (76.4%). 
Some authors consider C-section delivery as a factor that 
increases the chance of a woman to become a near miss case 
by five times; however, this association may be influenced 
by confounding factors.29 Thus, it is still debatable whether 
C-section is a risk factor for near miss, or if it is actually a 
consequence of this condition.17,29
As also shown in other studies, the C-section was the 
predominant type of delivery among cases of maternal near 
miss.16,28 These high rates may be acceptable among these 
patients due to the urgent gestational resolution and unfavorable 
cervical or fetal status.30 C-section also appeared as a protective 
factor for AFNO (PR = 0.20; 95% CI = 0.08 to 0.44; p < 0.05). This 
finding may be due to the fact that early pregnancy termination 
can prevent maternal near miss effects from appearing in the 
fetus, and thus there is a decrease in AFNO.
Premature birth occurred in 54.5% of cases. This high 
rate of prematurity, also observed in a study performed in 
Campinas, Brazil (65%) and one in Rio de Janeiro, Brazil (50%), 
can be explained by the severe situations experienced by these 
patients that can affect the fetus and lead to the need for 
premature pregnancy termination.15,17 Prematurity is referred 
to as the main factor associated with neonatal mortality.31 In 
the present study, the rate of AFNO among premature births 
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was high (44.1%), and preterm birth remained strongly 
associated with AFNO after the multivariate analysis (PR = 7.20; 
95% CI = 2.52 to 20.53; p < 0.05). 
Neonatal infection is among the three leading causes 
of fetal and neonatal death, and it is closely related with 
maternal infection.31  In the present study, women who 
developed endometritis had an almost four-fold higher 
association with AFNO. A review of antibiotic therapy 
protocols for the specific group of patients with maternal near 
miss can be evaluated in the future for treatment optimization 
and consequent improvement of fetal and neonatal morbidity 
and mortality.
Another interesting finding was the positive association 
between the laboratory criteria for near miss and AFNO 
(PR = 2.83; 95% CI = 1.08 to 7.39; p < 0.05), which was not 
observed with the clinical and management criteria. This 
could be explained by a higher frequency of laboratory criteria 
in patients still pregnant (56.2%), whereas the management 
criteria emerged more often postpartum (46.7%), and the 
clinical criteria had a lower percentage of pregnant women 
(40.2%). Thus, laboratory near miss can be investigated in other 
studies as a marker of not only severe maternal morbidity, but 
also of neonatal morbidity and mortality. 
The association found in the present study between history 
of miscarriage and AFNO was not maintained after multivariate 
analysis (PR = 2.42; 95% CI = 1.16 to 5.03; p < 0.05). A case-control 
population-based study demonstrated that among women 
with a history of miscarriage, the risk of fetal death was three 
times higher among nulliparous women, whereas among 
multiparous, there was no association between miscarriage 
and stillbirth, although this study did not analyze cases of 
maternal near miss.30
This supports the present model of multiple regression 
analysis that considers the inter-relationships of the 
variables, reducing the occurrence of erroneous findings 
that may eventually appear in the bivariate analysis. It can 
thus be inferred that, among patients with near miss, factors 
directly related to the pathology of the patient (severe PE, 
endometritis, PPA, and laboratory criteria for near miss) have 
greater influence on fetal and neonatal deaths than maternal 
characteristics, such as the obstetric background. 
The study limitations include the fact that the data were 
collected from medical records, which did not allow for the 
characterization of some near miss criteria, such as gasping, 
while some other information may not have been recorded, 
such as cyanosis and lactate levels.
Conclusion
The present study demonstrated the high frequency of 
fetal and neonatal deaths among women with near miss. 
It also disclosed the main factors associated with this fatal 
outcome, among which are severe PE, PPA, prematurity, and 
endometritis were already known to be associated with fetal 
and neonatal deaths. Others, such as C-section delivery, have 
shown conflicting results in the literature, but in patients with 
near miss this variable can be truly a protective factor against 
AFNO. The present study also suggested the association 
between laboratory criteria for near miss with AFNO, which 
was not observed with clinical or management criteria.
In this specific group of patients with maternal near miss, 
there is an overlap of factors that can lead to stillbirths and 
neonatal deaths. Identifying them is the first step to achieve 
decrease in neonatal and fetal mortality, as they can be used 
as basis for changes in antenatal and neonatal treatment 
protocols of maternal near miss cases. 
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